Burrows Scott L bought SYRE
September 1, 2026 · Form 4 insider transaction
Burrows Scott L bought 7,500 shares of Spyre Therapeutics, Inc. at $14.50 per share, a transaction worth $108.8K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
7,500
Price
$14.50
Total value
$108.8K
InsiderBurrows Scott L
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateSeptember 1, 2026
Filing dateSeptember 3, 2026
Shares owned after105,494
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on November 10, 2025.